Varanasi: In a major breakthrough in the global fight against the SARS-CoV-2 virus, a team of researchers from the Centre for Genetic Disorders at Ban.

Researchers from the UK conducted the first human challenge study of SARS-CoV-2, revealing long-lasting cognitive deficits in ...

The latest research deals a fatal blow to the fascistic conspiracy theory claiming the virus was created in a Chinese lab in ...

After SARS-CoV-2 infection, prevalent metformin use is associated with a slightly lower incidence of death or postacute sequalae of SARS-CoV-2.

RESEARCH COULD PAVE THE WAY FOR FUTURE COVID-19 TREATMENTS GROUNDBREAKING INNOVATION WITH REGARD TO AYURVEDA IN FIGHT AGAINST COVID-19Varanasi : In a significant breakthrough against the SARS-CoV-2 ...

Long COVID is common among veterans in the Airborne Hazards and Open Burn Pit Registry; however, the risk is not augmented by deployment exposures.

A new study led by Duke-NUS Medical School revealed that despite the recent pandemic, outbreak detection efforts remain under ...

Children born during the COVID-19 pandemic are no more likely than unexposed and pre-pandemic children to screen positive for ...

When it comes to where the new variant has been detected, right now, it’s more common in Europe. Currently, it’s been ...

The mRNA-1273 COVID-19 booster dose was safe and elicited robust immune responses among children aged 6 months to 5 years and 6 to 11 years.

The U.S. is coming down from its biggest COVID summer surge yet as a new subvariant emerges—but new vaccines are here, too.

Pfizer Canada ULC and BioNTech SE (Nasdaq: BNTX, "BioNTech") announced today that Health Canada has authorized the KP.2 ...